试验速览
- 阶段
- 2 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •1)Japanese cancer patients who can be hospitalized for clinical trial
- •2)Patients who are 20-74 years old at the time of informed consent
- •3)Patients who have been received cancer pain therapy with opioid for over 1 week
排除标准
- •1)Patients who have any complications or history of cardiac conduction disturbance
- •2)Patients who have any complications or history of abnormality of respiratory function
- •3)Patients with any organic encephalopathies
研究者
相似试验
未知
3 期
TK-641 Phase 3 StudyJPRN-jRCT2080221351TEIKOKU SEIYAKU CO., LTD.
未知
2 期
KD-370 Phase II study.The prevention of pertussis, diphtheria, tetanus, poliomyelitis, and infection caused by Haemophilus influenzae type b.JPRN-jRCT2080222866The Chemo-Sero-Therapeutic Research Institute
未知
2 期
KD-357 Phase II/III Studypreexposure prophylaxis against rabiesJPRN-jRCT2080222295The Chemo-Sero-Therapeutic Research Institute30
已完成
1 期
K-755 Phase 1 studyhealthy malesJPRN-jRCT2080224071Kowa Co., Ltd.78
未知
2 期
TK-FT Phase 2 Study (Efficacy and Safety Study)Breakthrough cancer painJPRN-jRCT2080220503TEIKOKU SEIYAKU CO., LTD.50